Invesaro

Stocks Health care EQ

NASDAQ · Health care

Equillium, Inc. (EQ)

It posted a net loss of $18M. In fiscal 2025 capital spending exceeded operating cash flow by $22.8M. At June 30, 2026 it held $57.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

Free, no password. An email when EQ files with the SEC.

Price
$1.50
-0.66% on the day · November 9, 2026
52-week range $0.76 to $3.54
Market cap
$95.1M

Key facts about Equillium, Inc.

Net worth
Equillium, Inc. has a market value (market cap) of $95.1M at the latest share price, and shareholders' equity of $56M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2024 revenue was $41.1M (+13.9% year on year), with a net loss of $8.1M.
Cash flow
In fiscal 2025 operations used $22.7M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Equillium, Inc.'s next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What Equillium, Inc. does

Equillium, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker EQ.

Revenue and profit by year

Revenue
FY22: $15.8M $15.8M FY22FY23: $36.1M $36.1M FY23FY24: $41.1M $41.1M FY24
Net income
FY18: -$13.3M -$13.3M FY18FY19: -$25.6M -$25.6M FY19FY20: -$29.8M -$29.8M FY20FY21: -$39.1M -$39.1M FY21FY22: -$62.4M -$62.4M FY22FY23: -$13.3M -$13.3M FY23FY24: -$8.1M -$8.1M FY24FY25: -$22.4M -$22.4M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025n/a-$23.6M-$22.4M-$0.39-$22.8M
2024$41.1M-$8.3M-$8.1M-$0.23-$19.1M
2023$36.1M-$14.5M-$13.3M-$0.38-$21.8M
2022$15.8M-$62.1M-$62.4M-$1.85-$9M
2021n/a-$37.8M-$39.1M-$1.36-$32.1M
2020n/a-$29.5M-$29.8M-$1.46-$24.8M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around November 12, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 13, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Latest SEC filings

What Equillium, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 4, 2026
  2. October 26, 2026
  3. October 5, 2026
  4. August 13, 2026
    Quarterly report 10-Q · period to June 30, 2026Diluted EPS -$0.04 versus -$0.16.
  5. August 13, 2026
  6. August 13, 2026
  7. August 12, 2026
  8. May 29, 2026
  9. May 15, 2026
  10. May 15, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on June 5, 2026. Insider transactions on SEC

Insider trades

What the people running Equillium, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
June 5, 2026 Connelly StephenPresident and CSO Sold 30,975 $2.94 $91.1K Form 4
June 5, 2026 Zedelmayer ChristineSr. Vice President and COO Exercised options 14,584 $0.79 $11.4K Form 4
June 5, 2026 Zedelmayer ChristineSr. Vice President and COO Soldpre-planned (10b5-1) 14,584 $2.93 $42.7K Form 4
June 4, 2026 Connelly StephenPresident and CSO Sold 200,000 $3.16 $632.8K Form 4
May 28, 2026 Zedelmayer ChristineSr. Vice President and COO Exercised options 7,292 $0.73 $5.3K Form 4
May 28, 2026 Zedelmayer ChristineSr. Vice President and COO Exercised options 48,512 $0.77 $37.4K Form 4
May 28, 2026 Zedelmayer ChristineSr. Vice President and COO Soldpre-planned (10b5-1) 55,604 $2.70 $150.1K Form 4
May 28, 2026 Zedelmayer ChristineSr. Vice President and COO Soldpre-planned (10b5-1) 200 $2.71 $542 Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns EQ

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Janus Henderson Group PLC13G, passive 9.99% 6,083,239 February 6, 2026
ADAR1 Capital Management, LLC13G, passive with 2 related filers 9.9% 6,603,754 May 15, 2026
RA Capital Management, L.P.13G, passive with 3 related filers 9.9% 6,480,209 March 20, 2026
Xiangmin Cui13G, passive with 4 related filers 8.9% 5,733,021 May 15, 2026
Adage Capital Management, L.P.13G, passive with 2 related filers 7.25% 4,832,767 August 12, 2026
Affinity Asset Advisors, LLC13G, passive with 1 related filers 6.5% 4,100,000 August 13, 2026
Woodline Partners LP13G, passive 5.9% 3,508,771 November 14, 2025
Aberdeen Group plc13G, passive with 1 related filers 5.3% 3,352,837 May 7, 2026

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 60 managers reported a position.

HolderSharesValueChange on quarter
Jupiter Topco LLC6,494,571$20.7Mnew
Decheng Capital LLC4,447,308$14.2M0
Affinity Asset Advisors, LLC4,100,000$13.1M+2,873,690
ADAR1 Capital Management, LLC3,758,569$12M+31,910
Aberdeen Group plc3,631,659$11.6M+278,822
Woodline Partners LP3,500,901$11.2M0
RA Capital Management, L.P.3,096,336$9.9M0
Stempoint Capital LP2,016,607$6.5Mnew
Vanguard Capital Management LLC1,822,812$5.8M+38,340
Eversept Partners, LP1,520,824$4.9M+21,831
Adage Capital Partners GP, L.L.C.1,390,253$4.4M-3,939,163
Renaissance Technologies LLC637,617$2M-19,347
Exome Asset Management LLC552,956$1.8Mnew
DG Capital Management, LLC463,396$1.5Mnew
Diadema Partners LP400,282$1.3M-33,562
Geode Capital Management, LLC381,175$1.2M+2,362
Balyasny Asset Management L.P.344,409$1.1M-1,294,361
Tudor Investment Corp ET AL320,100$1M+300,000
Ikarian Capital, LLC303,555$971.4K0
BlackRock, Inc.285,409$913.3K+157,557

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

2 insiders reported holding 824,611 shares in total, about $1.2M at the last price.

HolderSharesAs of
Connelly StephenPresident and CSO 762,025 June 5, 2026
Zedelmayer ChristineSr. Vice President and COO 62,586 June 5, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about EQ

What does Equillium, Inc. do?

Equillium, Inc. is a company in the Health care sector, listed on NASDAQ as EQ. Its shares trade on NASDAQ under the ticker EQ.

What is Equillium, Inc.'s net worth?

Equillium, Inc. has a market value (market cap) of $95.1M at the latest share price, and shareholders' equity of $56M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Equillium, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $18M.

When did Equillium, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from November 4, 2026.

When is Equillium, Inc.'s next earnings report?

Equillium, Inc.'s next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare EQ with

Compare EQ with any company

Follow EQ

Get an email when Equillium, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when EQ files with the SEC.

Where the numbers come from

Financial figures are the values Equillium, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.